Pharmaceutical R&D Productivity Forum 2008
20th - 21st October 2008
Hyatt San Diego, California
Optimizing R&D pipelines
High Throughput Genomics, Inc. Details
High Throughput Genomics, Inc.
Company Profile: High Throughput Genomics, Inc. (HTG) provides a platform for multiplex, bio-maker discovery and screening assays and instruments. Our company's goal is to speed the drug development process by providing multiplex, bio-marker driven discovery and screening systems. Our approach, which involves measuring multiple genes simultaneously in the same well with the same sample, provides the researcher a broader view of the underlying biology in their screening model. Our qNPA technology allows researchers to analyze multiplexed gene expression in hundreds or thousands of samples with a simple, no extraction, no RNA amplification, and no RNA labeling protocol with greater precision than ever before.
Key Products: High Throughput Genomics, Inc. (HTG) provides researchers the qNPATM ArrayPlate, a multiplexed, biomarker-driven drug discovery tool. Available in a standard or custom format, the ArrayPlate quantifies gene response data for up to 16 genes in a single sample well, providing a broader, more complete picture of the complex biology involved in drug responses and interactions. The goal of screening drug candidates for both efficacy and unwanted or toxic side-effects (ADME-Tox) in the initial screen can now be realized at a reasonable cost. In addition to its drug discovery applications, the multiplexed precision of qNPA technology makes it ideal for companion diagnostic applications of complex, multi-factorial disease.
Website:
www.htgenomics.com
